555 related articles for article (PubMed ID: 16552058)
1. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
[TBL] [Abstract][Full Text] [Related]
2. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.
Tartz S; Rüssmann H; Kamanova J; Sebo P; Sturm A; Heussler V; Fleischer B; Jacobs T
Vaccine; 2008 Nov; 26(47):5935-43. PubMed ID: 18804138
[TBL] [Abstract][Full Text] [Related]
3. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
Meraldi V; Romero JF; Kensil C; Corradin G
Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
[TBL] [Abstract][Full Text] [Related]
4. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
White KL; Snyder HL; Krzych U
J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
[TBL] [Abstract][Full Text] [Related]
5. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
[TBL] [Abstract][Full Text] [Related]
6. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
Fayolle C; Bauche C; Ladant D; Leclerc C
Vaccine; 2004 Dec; 23(5):604-14. PubMed ID: 15542180
[TBL] [Abstract][Full Text] [Related]
7. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
Reyes-Sandoval A; Sridhar S; Berthoud T; Moore AC; Harty JT; Gilbert SC; Gao G; Ertl HC; Wilson JC; Hill AV
Eur J Immunol; 2008 Mar; 38(3):732-41. PubMed ID: 18266272
[TBL] [Abstract][Full Text] [Related]
8. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
9. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes.
Fayolle C; Sebo P; Ladant D; Ullmann A; Leclerc C
J Immunol; 1996 Jun; 156(12):4697-706. PubMed ID: 8648115
[TBL] [Abstract][Full Text] [Related]
10. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.
Fayolle C; Ladant D; Karimova G; Ullmann A; Leclerc C
J Immunol; 1999 Apr; 162(7):4157-62. PubMed ID: 10201941
[TBL] [Abstract][Full Text] [Related]
11. Importance of the Immunodominant CD8
Gibbins MP; Müller K; Glover M; Liu J; Putrianti ED; Bauza K; Reyes-Sandoval A; Matuschewski K; Silvie O; Hafalla JCR
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719159
[TBL] [Abstract][Full Text] [Related]
12. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.
Romero P; Maryanski JL; Corradin G; Nussenzweig RS; Nussenzweig V; Zavala F
Nature; 1989 Sep; 341(6240):323-6. PubMed ID: 2477703
[TBL] [Abstract][Full Text] [Related]
13. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium berghei sporozoite challenge of vaccinated BALB/c mice leads to the induction of humoral immunity and improved function of CD8(+) memory T cells.
Tartz S; Deschermeier C; Retzlaff S; Heussler V; Sebo P; Fleischer B; Jacobs T
Eur J Immunol; 2013 Mar; 43(3):693-704. PubMed ID: 23229763
[TBL] [Abstract][Full Text] [Related]
15. C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei.
Bergmann-Leitner ES; Duncan EH; Leitner WW; Neutzner A; Savranskaya T; Angov E; Tsokos GC
Vaccine; 2007 Nov; 25(45):7732-6. PubMed ID: 17931754
[TBL] [Abstract][Full Text] [Related]
16. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
Doolan DL; Hoffman SL
J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
[TBL] [Abstract][Full Text] [Related]
17. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
18. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.
Simsova M; Sebo P; Leclerc C
Int J Med Microbiol; 2004 Apr; 293(7-8):571-6. PubMed ID: 15149033
[TBL] [Abstract][Full Text] [Related]
19. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
Dobaño C; Rogers WO; Gowda K; Doolan DL
Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
[TBL] [Abstract][Full Text] [Related]
20. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
